BiotechTube
Home/Mustang Bio/Manuel Litchman, M.D.
ML

Manuel Litchman, M.D.

President, Chief Executive Officer and Director

Mustang Bio

Therapeutic Areas

Oncology

Mustang Bio Pipeline

DrugIndicationPhase
MB-101High-Grade Glioma / GlioblastomaPhase 1
MB-106Relapsed/Refractory B-cell NHL & CLLPhase 1/2
MB-108Glioblastoma / Malignant GliomaPhase 1

Leadership Team at Mustang Bio

GF
Greg Furrow, M.S., FRQA
Chief Quality Officer
MS
Michael S. Weiss
Chairman of the Board of Directors
LA
Lindsay A. Rosenwald, M.D.
Director
AJ
Adam J. Chill
Director
View full Mustang Bio profile